Preemptive lamivudine in hepatitis B patients undergoing chemotherapy

Gastroenterology. 2004 Jun;126(7):1924; author reply 1924-5. doi: 10.1053/j.gastro.2004.04.043.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Hepatitis B, Chronic / complications*
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Lamivudine / administration & dosage*
  • Lymphoma / complications*
  • Lymphoma / drug therapy
  • Reverse Transcriptase Inhibitors / administration & dosage*
  • Secondary Prevention

Substances

  • Antineoplastic Agents
  • Reverse Transcriptase Inhibitors
  • Lamivudine